The Prescription Medicines Code of Practice Authority (PMCPA)—which operates the Code of Practice of the Association of the ...

Chinese radiopharmaceutical startup Eli Radiopharma has secured around 100 million yuan ($14.5 million) in fresh financing as ...

CSL Seqirus has entered into a pioneering long-term agreement with the Pan American Health Organization (PAHO) Regional ...

Spanish biologics CDMO 3PBIOVIAN has signed an agreement with Colombia’s National Cancer Institute to develop a biosimilar monoclonal antibody for an oncology indication, in a program aimed at ...

US biotech Regenxbio has announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial of RGX-202, its gene therapy for Duchenne muscular dystrophy (DMD).

Israeli clinical-stage drug developer Purple Biotech today announced that its chief executive, Gil Efron, will step down from his role as CEO effective August 2026.

Australian biotech Immutep’s shares plummeted 88.6% to A$0.045 today, after it announced that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod ...

Japan’s PRISM BioLab and USA-based Receptor.AI Inc have entered into a drug discovery collaboration agreement to develop an integrated, AI-navigated, physics-guided platform for the discovery of ...

Development & Commercialization and its parent Japan-based Otsuka Pharmaceutical have announced new open-label extension study data for repinatrabit (JNT-517), demonstrating early and ...

The European Medicines Agency’s (EMA) pharmacovigilance committee (PRAC) has completed its review of a safety signal of aseptic meningitis with French vaccines developer Valneva’s Ixchiq (live ...

US drugmaker Eli Lilly (NYSE: LLY) has warned that compounded versions of tirzepatide mixed with vitamin B12 may contain a previously unidentified impurity, raising fresh safety concerns around ...

A Swiss-based commercial-stage biotechnology and neurotechnology company developing digital neurotherapeutic treatments for neurological diseases and brain disorders. MindMaze Therapeutics combines ...